Filing Flows › Bio-Techne (TECH) › Q1 FY27
Bio-Techne (TECH) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Nov 6, 2026
Bio-Techne (TECH) reported revenue of $300M for the first quarter fiscal 2027 (Q1 FY27), +5% from a year earlier and -7% from the quarter before. Operating margin was 12.2%, net earnings $28.3M (9.4% of revenue).
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $300M | -7% | +5% |
| Gross profit | $197M | -7% | +5% |
| Operating profit | $36.6M | -51% | -23% |
| Net earnings | $28.3M | -48% | -26% |
| Operating cash flow | $73.1M | -23% | +165% |
| Free cash flow | $67.2M | -23% | +202% |
What changed
Revenue was $299.7M in Q1 FY27, up 5% year over year and down 7% from the previous quarter. Consumables was the largest line at 79% of revenue. Royalty added $8.8M year over year (up 157%), 67% of the total change. Services declined 18%.
Gross margin was 65.6%, unchanged from Q1 FY26. Operating profit was $36.6M, a 12.2% margin (down 4.4 points year over year). Operating profit fell $11.1M even though revenue rose $13.2M versus Q1 FY26, so costs grew faster than sales. Operating expenses grew 14% against revenue growth of 5%. The fastest-growing cost line was SG&A (+15%). Net earnings were $28.3M, down 26% year over year. The effective tax rate was 18.4%.
Operating cash flow was $73.1M (up 165% year over year), 258% of net earnings. Non-cash charges added back $23.7M of depreciation and amortization and $13.4M of share-based compensation. Working capital and other items added $7.7M. Capital expenditures of $5.9M left free cash flow of $67.2M.
Questions
What was Bio-Techne's revenue in the first quarter fiscal 2027?
Bio-Techne (TECH) reported revenue of $300M for the first quarter fiscal 2027 (Q1 FY27), +5% from a year earlier and -7% from the quarter before.
Was Bio-Techne profitable in the first quarter fiscal 2027?
Operating profit was $36.6M (12.2% of revenue) and net earnings $28.3M.
Source: Bio-Techne 10-Q on SEC EDGAR.